2023 - Research.com Medicine in Canada Leader Award
His Lymphoma study frequently draws connections to adjacent fields such as Hodgkin lymphoma. His Hodgkin lymphoma study frequently involves adjacent topics like Internal medicine. His research is interdisciplinary, bridging the disciplines of Follicular lymphoma and Internal medicine. He performs multidisciplinary study in Follicular lymphoma and Lymphoma in his work. By researching both Oncology and Gastroenterology, he produces research that crosses academic boundaries. Borrowing concepts from Oncology, he weaves in ideas under Gastroenterology. In his research, he performs multidisciplinary study on Diffuse large B-cell lymphoma and International Prognostic Index. Joseph M. Connors performs integrative International Prognostic Index and Diffuse large B-cell lymphoma research in his work. By researching both Cancer research and Genetics, he produces research that crosses academic boundaries.
Joseph M. Connors integrates many fields in his works, including Lymphoma and Follicular lymphoma. His Follicular lymphoma study frequently intersects with other fields, such as Internal medicine. His research brings together the fields of Vinblastine and Internal medicine. In his research, he performs multidisciplinary study on Oncology and Gastroenterology. While working on this project, Joseph M. Connors studies both Gastroenterology and Oncology. In his papers, he integrates diverse fields, such as Chemotherapy and Rituximab. With his scientific publications, his incorporates both Rituximab and Chemotherapy. While working on this project, Joseph M. Connors studies both Immunology and Antibody. Joseph M. Connors connects Antibody with Immunology in his research.
Phenotype and Mutation are the subject areas of his Gene study. Joseph M. Connors performs multidisciplinary study in the fields of Mutation and Gene via his papers. By researching both Lymphoma and International Prognostic Index, he produces research that crosses academic boundaries. His Internal medicine study frequently links to adjacent areas such as Neutropenia. In his articles, he combines various disciplines, including Neutropenia and Chemotherapy. He performs integrative Chemotherapy and Progression-free survival research in his work. Joseph M. Connors combines Oncology and Gastroenterology in his research. In his study, he carries out multidisciplinary Gastroenterology and Oncology research. Joseph M. Connors integrates Cyclophosphamide and Rituximab in his studies.
Lymphoma is closely attributed to Hodgkin lymphoma in his work. He regularly links together related areas like Lymphoma in his Hodgkin lymphoma studies. He conducts interdisciplinary study in the fields of Chemotherapy and CD20 through his research. In his works, Joseph M. Connors undertakes multidisciplinary study on CD20 and Chemotherapy. He integrates Cyclophosphamide and Dacarbazine in his studies. In his papers, he integrates diverse fields, such as Dacarbazine and ABVD. While working on this project, he studies both ABVD and Vinblastine. He integrates several fields in his works, including Vinblastine and Hodgkin's lymphoma. In his papers, he integrates diverse fields, such as Hodgkin's lymphoma and Bleomycin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circos: An information aesthetic for comparative genomics
Martin I Krzywinski;Jacqueline E Schein;Inanc Birol;Joseph Connors.
Genome Research (2009)
A predictive model for aggressive non-Hodgkin's lymphoma
M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage.
The New England Journal of Medicine (1993)
Revised response criteria for malignant lymphoma
Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne.
Journal of Clinical Oncology (2007)
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors.
The New England Journal of Medicine (2002)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne.
Stromal gene signatures in large-B-cell lymphomas
G Lenz;G Wright;S S Dave;W Xiao.
The New England Journal of Medicine (2008)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Morin Rd;Johnson Na;Severson Tm;Mungall Aj.
Nature Genetics (2010)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D Morin;María Méndez-Lago;Andrew J Mungall;Rodrigo Goya.
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar.
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
Anas Younes;Ajay K. Gopal;Scott E. Smith;Stephen M. Ansell.
Journal of Clinical Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: